Abstract
Curative Inc., created in January 2020 with the intent of improving diagnostics for sepsis, pivoted to SARS-CoV-2 testing in March 2020 as it became clear that the United States needed additional testing capacity. Cell Systems spoke with Curative cofounders Fred Turner, Dr. Isaac Turner, and Dr. Vlad Slepnev about their work developing and deploying a COVID-19 oral fluid test at scale with unprecedented speed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
